Mortality Reduction After Oral Azithromycin: Mortality Study
Status:
Completed
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
Our long-term goal is to more precisely define the role of mass azithromycin treatments as an
intervention for reducing childhood mortality. We propose a single multi-site
(multi-country), cluster-randomized trial comparing communities randomized to oral
azithromycin with those randomized to placebo. We hypothesize that mass azithromycin
treatments will reduce childhood mortality.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
Bill and Melinda Gates Foundation Johns Hopkins University London School of Hygiene and Tropical Medicine